Advansta Inc. products

Advansta’s high-quality HRP-conjugated secondary antibodies offer unparalleled sensitivity and performance for immunoblotting and ELISA applications. These secondary HRP conjugated antibodies are optimized with Advansta`s protein detection systems including WesternBright ECL, WesternBright Quantum, WesternBright Sirius and ElisaBright.

AdvanBlock™-Fluor is a novel blocking solution, optimized to enhance specific antibody-antigen interactions for fluorescent Western Blots. This all-in-one blocking solution is designed to improve sensitivity and decrease overall background. Non-specific binding caused by low quality antibodies is reduced while signal from the specific antibody-antigen complex is stabilized and enhanced. AdvanBlock™-Fluor is provided as a convenient ready-to-use 1x solution intended to directly replace other commonly used blocking buffers for fluorescent Western Blotting.

In December of 2019, the SARS-CoV-2 virus, which causes the disease COVID-19, was first detected in Wuhan, China. The SARS-CoV-2 virus is a single-stranded RNA coronavirus that causes respiratory infections. The rapid spread of COVID-19 has resulted in a global pandemic which has caused an unprecedented social and economic disruption to daily life.